Related Experiment Video
Updated: Aug 19, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Recurrent amiodarone pulmonary toxicity
A Chendrasekhar1, R A Barke, P Druck
1University of Minnesota, Minneapolis, USA.
Abstract:
Amiodarone, a widely used antiarrhythmic drug, is associated with pulmonary toxicity, with an estimated mortality of 1% to 33%. Standard treatment for amiodarone pulmonary toxicity (APT) has been discontinuance of the drug and steroid therapy. We report a case of APT that recurred after withdrawal of steroids and failed to respond to reinstatement of steroid therapy. Recurrent APT is a rare clinical entity that has been reported only twice in recent literature.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Pneumothorax-II
Clinical Manifestations:
Drug Toxicity: Risk factors
Drug Toxicity: Allergic Reactions
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

